Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
A Randomized Controlled Trial With an Anti-CCL2 (Anti-Monocyte Chemotactic Protein 1) Monoclonal Antibody in Patients With Rheumatoid Arthritis
*Correspondence: Yu Zhao, [email protected]
Op dit moment is er onvoldoende bewijs om te concluderen dat BPC-157 veilig en effectief is voor de behandeling van blessures, darmziekten of andere medische aandoeningen
Journal of Pathology and Translational Medicine 50(6): 411418
Soberanes S, Misharin AV, Jairaman A, Morales-Nebreda L, McQuattie-Pimentel AC, Cho T, Hamanaka RB, Meliton AY, Reyfman PA, Walter JM, Chen CI, Chi M, Chiu S, Gonzalez-Gonzalez FJ, Antalek M, Abdala-Valencia H, Chiarella SE, Sun KA, Woods PS, Ghio AJ, Jain M, Perlman H, Ridge KM, Morimoto RI, Sznajder JI, Balch WE, Bhorade SM, Bharat A, Prakriya M, Chandel NS, Mutlu GM, Scott Budinger GR
W., Sherman, B
US$ 24.61
US$ 26.70
US$ 26.59
